Top

Published in:

01-10-2013 | Lower Urinary Tract Symptoms and Voiding Dysfunction (G Badlani and H Goldman, Section Editors)

Myofascial Trigger Points of the Pelvic Floor: Associations with Urological Pain Syndromes and Treatment Strategies Including Injection Therapy

Authors: Robert M. Moldwin, Jennifer Yonaitis Fariello

Published in: Current Urology Reports | Issue 5/2013

Abstract

Myofascial trigger points (MTrP), or muscle “contraction knots,” of the pelvic floor may be identified in as many as 85 % of patients suffering from urological, colorectal and gynecological pelvic pain syndromes; and can be responsible for some, if not all, symptoms related to these syndromes. Identification and conservative treatment of MTrPs in these populations has often been associated with impressive clinical improvements. In refractory cases, more “aggressive” therapy with varied trigger point needling techniques, including dry needling, anesthetic injections, or onabotulinumtoxinA injections, may be used, in combination with conservative therapies.

Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002;65:653–62. WB SAUNDERS CO.PubMed

Bron C, Dommerholt JD. Etiology of myofascial trigger points. Curr Pain Headache Rep. 2012;16:439–44.PubMedCrossRef

Simons DG. New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil. 2008;89:157–9.PubMedCrossRef

Shah JP. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol. 2005;99:1977–84.PubMedCrossRef

•• Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89:16–23. This study details specific biochemical abnormalities identified in MTrPs. PubMedCrossRef

Borg-Stein J, Simons DG. Myofascial pain. Arch Phys Med Rehabil. 2002;83:S40–7.PubMedCrossRef

Kuan T-S. Current studies on myofascial pain syndrome. Curr Pain Headache Rep. 2009;13:365–9.PubMedCrossRef

Srinivasan AK, Kaye JD, Moldwin R. Myofascial dysfunction associated with chronic pelvic floor pain: management strategies. Curr Pain Headache Rep. 2007;11:359–64.PubMedCrossRef

Peters KM, Carrico DJ. Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epithelium. Curr Urol Rep. 2006;7:450–5.PubMedCrossRef

10.

Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185:2162–70.PubMedCrossRef

11.

Berger RE, Ciol MA, Rothman I, Turner JA. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol. 2007;7:17.PubMedCrossRef

12.

•• Pastore EA, Katzman WB. Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain. JOGNN. 2012;41:680–91. A comprehensive review of myofascial pelvic pain in female patients with further emphasis on patient evaluation. CrossRef

13.

Groysman V. Vulvodynia: new concepts and review of the literature. Dermatol Clin. 2010;28(4):681–96.PubMedCrossRef

14.

Bartley JM, Carrico DJ, Gilleran JP, Sirls LT, Peters KM. Chronic pelvic pain in women: common etiologies and management approach recommendations. Clin Pract. 2013;10:89–102.CrossRef

15.

Zolnoun D, Hartmann K, Lamvu G, As-Sanie S, Maixner W, Steege J. A conceptual model for the pathophysiology of vulvar vestibulitis syndrome. Obstet Gynecol Surv. 2006;61:395–401. quiz423.PubMedCrossRef

16.

Doggweiler-Wiygul R. Urologic myofascial pain syndromes. Curr Pain Headache Rep. 2004;8:445–51.PubMedCrossRef

17.

Hong C-Z. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. 2006;10:345–9.PubMedCrossRef

18.

Chen S-M, Chen J-T, Kuan T-S, Hong J, Hong C-Z. Decrease in pressure pain thresholds of latent myofascial trigger points in the middle finger extensors immediately after continuous piano practice. J Muscoskel Pain. 2000;8:83–92.CrossRef

19.

Kawakita K, Itoh K, Okada K. Experimental model of trigger points using eccentric exercise. J Muscoskel Pain. 2008;16:29–35.CrossRef

20.

Gerwin R. Differential diagnosis of trigger points. J Muscoskel Pain. 2005;12:23–8.CrossRef

21.

Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep. 2004;8:463–7.PubMedCrossRef

22.

Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, et al. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology. 2004;64:862–5.PubMedCrossRef

23.

Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. JURO. 2001;166:2226–31.

24.

Fitzgerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. JURO. 2012;187:2113–8.

25.

Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. JURO. 2013;189:S75–85.

26.

Montenegro MLLS, Gomide LB, Mateus-Vasconcelos EL, Rosa-e-Silva JC, Candido-dos-Reis FJ, Nogueira AA, et al. Abdominal myofascial pain syndrome must be considered in the differential diagnosis of chronic pelvic pain. Eur J Obstet Gynecol Reprod Biol. 2009;147:21–4.PubMedCrossRef

27.

Kim DS, Jeong TY, Kim YK, Chang WH, Yoon JG, Lee SC. Usefulness of a myofascial trigger point injection for groin pain in patients with chronic prostatitis/chronic pelvic pain syndrome: A pilot study. Arch Phys Med Rehab. 2013; 94(5)930-6.

28.

Malanga G, Wolff E. Evidence-informed management of chronic low back pain with trigger point injections. Spine J. 2008;8:243–52.PubMedCrossRef

29.

Simons D. Myofascial pain syndromes-trigger points. J Muscoskel Pain. 2004;11:47–55.CrossRef

30.

Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth Pain Med. 1997;22:89–101.CrossRef

31.

Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82:986–92.PubMedCrossRef

32.

Ay S, Evcik D, Tur BS. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol. 2009;29:19–23.PubMedCrossRef

33.

Tsai C-T, Hsieh L-F, Kuan T-S, Kao M-J, Chou L-W, Hong C-Z. Remote effects of dry needling on the irritability of the myofascial trigger point in the upper trapezius muscle. Am J Phys Med Rehabil. 2010;89:133–40.PubMedCrossRef

34.

Tseng C-L, Kao M-J, Chou L-W, Hong C-Z. Injection of remote myofascial trigger points for pain control: a case report. Tw J Phys Med Rehabil. 2008;36:53–8.

35.

Chou L-W, Hong JY, Hong C-Z. A new technique for acupuncture therapy and its effectiveness in treating fibromyalgia syndrome: a case report. J Muscoskel Pain. 2008;16:193–8.CrossRef

36.

Ga H, Choi J-H, Park C-H, Yoon H-J. Dry needling of trigger points with and without paraspinal needling in myofascial pain syndromes in elderly patients. J Alternative Complement Med. 2007;13:617–24.CrossRef

37.

Huguenin L. Effect of dry needling of gluteal muscles on straight leg raise: a randomised, placebo controlled, double blind trial. Br J Sports Med. 2005;39:84–90.PubMedCrossRef

38.

Vulfsons S, Ratmansky M, Kalichman L. Trigger point needling: techniques and outcome. Curr Pain Headache Rep. 2012;16:407–12.PubMedCrossRef

39.

Langford CF, Udvari Nagy S, Ghoniem GM. Levator ani trigger point injections: an underutilized treatment for chronic pelvic pain. Neurourol Urodyn. 2006;26:59–62.CrossRef

40.

Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994;73:256–63.PubMedCrossRef

41.

Doggweiler-Wiygul R, Wiygul JP. Interstitial cystitis, pelvic pain, and the relationship to myofascial pain and dysfunction: a report on four patients. World J Urol. 2002;20:310–4.PubMed

42.

Criscuolo CM. Interventional approaches to the management of myofascial pain syndrome. Curr Pain Headache Rep. 2001;5:407–11.PubMedCrossRef

43.

Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth. 2010;105:i97–i107.PubMedCrossRef

44.

Ikeda Y, Zabbarova IV, Birder LA, de Groat WC, McCarthy CJ, Hanna-Mitchell AT, et al. Botulinum neurotoxin serotype a suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder. Eur Urol. 2012;62:1157–64.PubMedCrossRef

45.

•• Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–33. First report showing that BTX-A inhibits inflammation induced pain through nociceptive sensory nerves. PubMedCrossRef

46.

Allergan, Inc. 2013. Highlights of prescribing information. Retrieved from http://www.allergan.com/assets/pdf/botox_pi.pdf.

47.

Jeynes LC, Gauci CA. Evidence for the Use of Botulinum toxin in the chronic pain setting—a review of the literature. Pain Pract. 2008;8:269–76.PubMedCrossRef

48.

Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol. 2004;44:46–50.PubMedCrossRef

49.

•• Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108:915–23. First RTC to demonstrate that BTX-A injections into the pelvic floor musculature improves pelvic pain and dyspareunia. PubMedCrossRef

50.

Gottsch HP, Yang CC, Berger RE. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. Scand J Urol Nephrol. 2011;45:72–6.PubMedCrossRef

51.

• Nesbitt-Hawes EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A. Toxicon. 2013;63:83–7. This study demonstrated continued efficacy with sequential BTX-A injections. PubMedCrossRef

52.

Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000;85:101–5.PubMedCrossRef

53.

Cox B, Durieux ME, Marcus MAE. Toxicity of local anesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):111–136.

54.

Loeser, JD (Ed.). (2001). Bonica's management of pain (3rd ed.). Philadelphia, PA: Lippincott Williams & Willams.

Title: Myofascial Trigger Points of the Pelvic Floor: Associations with Urological Pain Syndromes and Treatment Strategies Including Injection Therapy
Authors: Robert M. Moldwin
Jennifer Yonaitis Fariello
Publication date: 01-10-2013
Publisher: Springer US
Published in: Current Urology Reports / Issue 5/2013
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-013-0360-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Myofascial Trigger Points of the Pelvic Floor: Associations with Urological Pain Syndromes and Treatment Strategies Including Injection Therapy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Critical Evaluation of Modified Templates and Current Trends in Retroperitoneal Lymph Node Dissection

β3-Receptor Agonists for Overactive Bladder—New Frontier or More of the Same?

Controversies in the Management of Stage 1 Non-Seminomatous Germ Cell Tumors

Late Relapse of Testis Cancer

Urodynamics: Examining the Current Role of UDS Testing. What is the Role of Urodynamic Testing in Light of Recent AUA Urodynamics and Overactive Bladder Guidelines and the VALUE Study?

Latissimus Dorsi Detrusor Myoplasty to Restore Voiding in Patients with an Acontractile Bladder – Fact or Fiction?